+ 7 (495) 684-04-00

Ideas

Our observations, insights and news from the investment world

Waiting for the Seasonal sell signal in the NASDAQ, other sector trades come to and end in June. Gearing up for a sideways market is the plan now, until the strong months again come later this year.
To access this post, you must purchase Subscription Plan – AVC Pro.
MercadoLibre and PagSeguro are growing their fintech efforts. AT&T cuts its dividend. Semiconductors remain newsworthy.
We see option activity picking up in our favorite Latin American payment service company. Morgan Stanley analysts expect stronger than expected growth. The chart looks interesting for the stock to run again.
To access this post, you must purchase Subscription Plan – AVC Pro.
Valuations are compelling in Emerging Markets, but momentum is weak. Seasonally, June is weak. Gold and silver show strength against dollar weakness.
Tesla, the best innovator with first mover advantage in EV space, gets all the attention. It has a lofty multiple while other auto makers were shunned. Recently, new products signal a change.
To access this post, you must purchase Subscription Plan – AVC Pro.
JPMorgan makes the case for an early stage growth opportunity within an established company: Urban Air Travel.
To access this post, you must purchase Subscription Plan – AVC Pro.
Animal Health companies are showing strength recently. Four stocks are poised for new highs as demand for products remain elevated, according to Credit Suisse.
To access this post, you must purchase Subscription Plan – AVC Pro.
A buying opportunity in a medtech company arises as a competitor product pulls out.
To access this post, you must purchase Subscription Plan – AVC Pro.
Divergent markets pervade June. The NASDAQ ends its best 8 months and the Dow can really suffer, especially in post-election years.
To access this post, you must purchase Subscription Plan – AVC Pro.
The debate on the sustainability of inflation is alive! Markets react and traders battle out their Feds next move. Retail and consumer discretionary stocks look weak, while semiconductors and car resellers could bounce. Biotech sits on support.
Scroll to Top